ELEVANCE HEALTH INC (ELV) Institutional Ownership Changes & 13F Activity

ELEVANCE HEALTH INC (elv) institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions among tracked filers. Notable filers include Sequoia Fund, Renaissance Technologies LLC, Brave Warrior Advisors, Vulcan Value Partners, and Sound Shore Management.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2025Sequoia Financial AdvisorsBuy9136,717$2,921,677
Q1 2025Yacktman Asset ManagementBuy435342,468$148,959,881
Q1 2025Lountzis Asset ManagementSell-177755$312,434
Q1 2025Dodge & Cox Stock FundBuy1001,200$521,952
Q4 2024First Eagle U.S. ValueBuy1,039,6123,225,339$1,189,827,627
Q4 2024Sequoia FundBuy139,4201,143,953$422,004,262
Q4 2024Renaissance Technologies LLCBuy115,000122,973$45,364,740
Q4 2024Vulcan Value PartnersBuy114,607393,892$145,233,542
Q4 2024Eagle Capital ManagementSell-35,6141,564,616$577,186,842
Q4 2024Brave Warrior AdvisorsSell-11,4361,629,977$601,298,515
Q4 2024Hancock Classic ValueBuy1,629193,997$71,565,493
Q4 2024Yacktman Asset ManagementSell-1,105342,033$126,175,974
Q4 2024Sequoia Financial AdvisorsSell-8615,804$2,141,082
Q3 2024First Eagle U.S. ValueBuy127,4442,185,727$1,136,578,175
Q3 2024Vulcan Value PartnersSell-65,653279,285$145,228,200
Q3 2024Yacktman Asset ManagementSell-28,717343,138$178,431,760
Q3 2024Sequoia FundSell-19,5381,004,533$522,357,160
Q3 2024Eagle Capital ManagementSell-8,2861,600,230$832,119,600
Q3 2024Brave Warrior AdvisorsBuy8,2861,641,413$853,534,760
Q3 2024Sound Shore ManagementSell-2,572119,497$62,138,440
Q3 2024Sequoia Financial AdvisorsBuy3376,665$3,465,902
Q3 2024Lountzis Asset ManagementBuy177932$484,640
Q3 2024Hancock Classic ValueBuy113192,368$100,031,360
Q2 2024First Eagle U.S. ValueBuy275,7082,058,283$1,115,301,464
Q2 2024Sequoia FundSell-50,6141,024,071$554,903,112
Q2 2024Vulcan Value PartnersSell-44,802344,938$186,745
Q2 2024Eagle Capital ManagementBuy42,2801,608,516$871,590,480
Q2 2024Sound Shore ManagementSell-32,574122,069$66,144,309
Q2 2024Brave Warrior AdvisorsSell-12,7101,633,127$884,926,196
Q2 2024Yacktman Asset ManagementSell-2,765371,855$201,493,350

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.

Related ELV insights